1. Home
  2. ROCK vs HRMY Comparison

ROCK vs HRMY Comparison

Compare ROCK & HRMY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Gibraltar Industries Inc.

ROCK

Gibraltar Industries Inc.

HOLD

Current Price

$50.47

Market Cap

2.0B

Sector

N/A

ML Signal

HOLD

Logo Harmony Biosciences Holdings Inc.

HRMY

Harmony Biosciences Holdings Inc.

HOLD

Current Price

$38.25

Market Cap

2.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ROCK
HRMY
Founded
1972
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.0B
2.2B
IPO Year
1993
2020

Fundamental Metrics

Financial Performance
Metric
ROCK
HRMY
Price
$50.47
$38.25
Analyst Decision
Strong Buy
Analyst Count
0
9
Target Price
N/A
$51.33
AVG Volume (30 Days)
314.6K
734.0K
Earning Date
10-30-2025
11-04-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
50.44
EPS
0.13
3.17
Revenue
$1,383,811,000.00
$825,944,000.00
Revenue This Year
N/A
$23.11
Revenue Next Year
$6.98
$16.15
P/E Ratio
$374.63
$12.13
Revenue Growth
23.49
21.13
52 Week Low
$42.86
$25.52
52 Week High
$75.08
$40.93

Technical Indicators

Market Signals
Indicator
ROCK
HRMY
Relative Strength Index (RSI) 44.23 59.90
Support Level $48.76 $37.12
Resistance Level $51.96 $39.60
Average True Range (ATR) 1.52 1.31
MACD 0.40 -0.32
Stochastic Oscillator 41.83 36.53

Price Performance

Historical Comparison
ROCK
HRMY

About ROCK Gibraltar Industries Inc.

Gibraltar Industries Inc manufactures and provides products and services for the Renewable energy, Residential, Agtech, and Infrastructure markets. The Renewables Segment is engaged in designing, engineering, manufacturing, and installing solar racking and electrical balance systems. Agtech Segment provides growing and processing solutions including the designing, engineering, manufacturing, full-scope construction, maintenance, and support of greenhouses and indoor growing operations, and botanical extraction systems. It derives key revenue from the Residential segment which offers roof and foundation ventilation products, single point and centralized mail systems electronic package solutions, and Retractable awnings and gutter guards, among other products.

About HRMY Harmony Biosciences Holdings Inc.

Harmony Biosciences Holdings Inc is a commercial-stage pharmaceutical company focused on developing and commercializing therapies for patients living with rare neurological diseases who have unmet medical needs. The company's product WAKIX (pitolisant) is a molecule with a novel mechanism of action specifically designed to increase histamine signaling in the brain by binding to H3 receptors and is used for the treatment of cataplexy in adult patients with narcolepsy. The other drug candidates in its pipeline are Pitolisant, HBS-102 (MCHR1 antagonist), BP1.15205 (orexin-2 receptor agonist), ZYN002 (cannabidiol gel), EPX-100 (clemizole hydrochloride), and EPX-200 (lorcaserin), among others.

Share on Social Networks: